Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

21-30 of 4090 results

Catalogue Number:

PX-TA1806

Category:

G

Adebrelimab Biosimilar – Anti-PDL1 mAb – Research Grade

Target: PDL1
Target Alias Name: Adebrelimab//PDL1/anti-PDL1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1120

Category:

G

Adecatumumab Biosimilar – Anti-EPCAM mAb – Research Grade

Target: EPCAM
Target Alias Name: Adecatumumab/MT201/EPCAM/anti-EPCAM
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1803

Category:

G

Adintrevimab Biosimilar – Anti-Spike RBD mAb – Research Grade

Target: Spike RBD
Target Alias Name: Adintrevimab/ADG-2/ ADG-20/Spike RBD/anti-Spike RBD
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda2
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1335

Category:

G

Aducanumab Biosimilar – Anti-APP Abeta mAb – Research Grade

Target: APP Abeta
Target Alias Name: Aducanumab/BART/BIIB-037/APP Abeta/anti-APP Abeta
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1401

Category:

G

Afasevikumab Biosimilar – Anti-IL17A / IL17F mAb – Research Grade

Target: IL17A / IL17F
Target Alias Name: Afasevikumab/MCAF-5352A/NI-1401/RG-7624/RO5553110/IL17A / IL17F/anti-IL17A / IL17F
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1088

Category:

G

Afelimomab Biosimilar – Anti-TNFSF2/ TNF-alpha/ TNFA mAb – Research Grade

Target: TNFSF2/ TNF-alpha/ TNFA
Target Alias Name: Afelimomab/MAK-195F/TNFSF2/ TNF-alpha/ TNFA/anti-TNFSF2/ TNF-alpha/ TNFA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: F(ab')2-G3-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1016

Category:

G

Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade

Target: VEGF
Target Alias Name: Aflibercept/Aflibercept/VEGF/anti-VEGF
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: hG1-Fc
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PTX18461-100

Category:

G

AFP / Alpha-fetoprotein Monoclonal Monoclonal Antibody 6B1

Target: AFP
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Mouse
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1122

Category:

G

Al-901 Biosimilar – Anti-IGHE mAb – Research Grade

Target: IGHE
Target Alias Name: Al-901/AL-901/IGHE/anti-IGHE
Species Reactivity: Human
Type: Primary Recombinant
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1167

Category:

G

Alacizumab Biosimilar – Anti-KDR/ VEGFR2/ CD309 mAb – Research Grade

Target: KDR/ VEGFR2/ CD309
Target Alias Name: Alacizumab/CDP791/g165 DFM-PEG/KDR/ VEGFR2/ CD309/anti-KDR/ VEGFR2/ CD309
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: di-Fab'
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression